Literature DB >> 19763489

Comprehensive quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry.

Jacek Bielawski1, Jason S Pierce, Justin Snider, Barbara Rembiesa, Zdzislaw M Szulc, Alicja Bielawska.   

Abstract

There has been a recent explosion in research concerning novel bioactive sphingolipids (SPLs) such as ceramide (Cer), sphingosine (Sph), and sphingosine 1-phosphate (Sph-1P) and this has necessitated the development of accurate and user-friendly methodology for analyzing and quantitating the endogenous levels of these molecules. ESI/MS/MS methodology provides a universal tool used for detecting and monitoring changes in SPL levels and composition from biological materials. Simultaneous ESI/MS/MS analysis of sphingoid bases (SBs), sphingoid base 1-phosphates (SB-1Ps), ceramides (Cers), ceramide 1-phosphates (Cer-1P), glucosyl/galactosyl-ceramides (Glu-Cers), and sphingomyelins (SMs) is performed on a Thermo Fisher Scientific triple quadrupole mass spectrometer operating in a multiple reaction monitoring (MRM) positive ionization mode. Biological materials (cells, tissues, or physiological fluids) are fortified with internal standards (ISs), extracted into a one-phase neutral organic solvent system, and analyzed by a LC/MS/MS system. Qualitative analysis (identification) of SPLs is performed by a Parent Ion scan of a common fragment ion characteristic for a particular class of SPLs. Quantitative analysis is based on calibration curves generated by spiking an artificial matrix with known amounts of target analyte, synthetic standards, and an equal amount of IS. The calibration curves are constructed by plotting the peak area ratios of analyte to the respective IS against concentration, using a linear regression model. This robust analytical procedure can determine the composition of endogenous sphingolipids (ESPLs) in varied biological materials and achieve a detection limit of subpicomole level. This methodology constitutes a "Lipidomic" approach to study the SPLs metabolism, defining a function of distinct subspecies of individual bioactive SPL classes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19763489     DOI: 10.1007/978-1-60761-322-0_22

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  98 in total

1.  Selective Ah receptor ligands mediate enhanced SREBP1 proteolysis to restrict lipogenesis in sebocytes.

Authors:  Gulsum E Muku; Nicholas Blazanin; Fangcong Dong; Philip B Smith; Diane Thiboutot; Krishne Gowda; Shantu Amin; Iain A Murray; Gary H Perdew
Journal:  Toxicol Sci       Date:  2019-06-21       Impact factor: 4.849

2.  Central nervous system dysfunction in a mouse model of FA2H deficiency.

Authors:  Kathleen A Potter; Michael J Kern; George Fullbright; Jacek Bielawski; Steven S Scherer; Sabrina W Yum; Jian J Li; Hua Cheng; Xianlin Han; Jagadish Kummetha Venkata; P Akbar Ali Khan; Bärbel Rohrer; Hiroko Hama
Journal:  Glia       Date:  2011-04-13       Impact factor: 7.452

3.  Multiple actions of doxorubicin on the sphingolipid network revealed by flux analysis.

Authors:  Justin M Snider; Magali Trayssac; Christopher J Clarke; Nicholas Schwartz; Ashley J Snider; Lina M Obeid; Chiara Luberto; Yusuf A Hannun
Journal:  J Lipid Res       Date:  2018-12-20       Impact factor: 5.922

4.  Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate.

Authors:  Iryna Sutter; Rebekka Park; Alaa Othman; Lucia Rohrer; Thorsten Hornemann; Markus Stoffel; Olivier Devuyst; Arnold von Eckardstein
Journal:  J Lipid Res       Date:  2014-06-20       Impact factor: 5.922

5.  A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors.

Authors:  Carolyn D Britten; Elizabeth Garrett-Mayer; Steven H Chin; Keisuke Shirai; Besim Ogretmen; Tricia A Bentz; Alan Brisendine; Kate Anderton; Susan L Cusack; Lynn W Maines; Yan Zhuang; Charles D Smith; Melanie B Thomas
Journal:  Clin Cancer Res       Date:  2017-04-18       Impact factor: 12.531

6.  Ceramide channels: influence of molecular structure on channel formation in membranes.

Authors:  Meenu N Perera; Vidyaramanan Ganesan; Leah J Siskind; Zdzislaw M Szulc; Jacek Bielawski; Alicja Bielawska; Robert Bittman; Marco Colombini
Journal:  Biochim Biophys Acta       Date:  2012-02-15

7.  Cell density-dependent reduction of dihydroceramide desaturase activity in neuroblastoma cells.

Authors:  Stefka D Spassieva; Mehrdad Rahmaniyan; Jacek Bielawski; Christopher J Clarke; Jacqueline M Kraveka; Lina M Obeid
Journal:  J Lipid Res       Date:  2012-02-29       Impact factor: 5.922

8.  Changes in glucosylceramide structure affect virulence and membrane biophysical properties of Cryptococcus neoformans.

Authors:  Shriya Raj; Saeed Nazemidashtarjandi; Jihyun Kim; Luna Joffe; Xiaoxue Zhang; Ashutosh Singh; Visesato Mor; Desmarini Desmarini; Julianne Djordjevic; Daniel P Raleigh; Marcio L Rodrigues; Erwin London; Maurizio Del Poeta; Amir M Farnoud
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-09-01       Impact factor: 3.747

9.  Cytokine-induced release of ceramide-enriched exosomes as a mediator of cell death signaling in an oligodendroglioma cell line.

Authors:  Maria Podbielska; Zdzisław M Szulc; Ewa Kurowska; Edward L Hogan; Jacek Bielawski; Alicja Bielawska; Narayan R Bhat
Journal:  J Lipid Res       Date:  2016-09-13       Impact factor: 5.922

Review 10.  Sphingolipids: the nexus between Gaucher disease and insulin resistance.

Authors:  Maria Fuller
Journal:  Lipids Health Dis       Date:  2010-10-11       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.